Shanghai Pharmaceuticals Holding Co., Ltd
2607.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.98B
Close$
$32.51
190.5% upside
Current Fair Value
190.5% upsideUndervalued by 190.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $63.98 Billion |
|---|---|
| Enterprise Value | $96.30 Billion |
| Dividend Yield | $0.54 (3.42%) |
| Earnings per Share | $1.54 |
| Beta | 0.22 |
| Outstanding Shares | 3,708,361,809 |
Return
| Return on Equity | 6.08% |
|---|---|
| Return on Assets | 1.97% |
| Return on Invested Capital | 11.85% |
Valuation & Multiples
| P/E Ratio | 12.93 |
|---|---|
| PEG | -38.68 |
| Price to Sales | 0.15 |
| Price to Book Ratio | 0.45 |
| Enterprise Value to Revenue | 0.33 |
| Enterprise Value to EBIT | 8.05 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.7 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$0.76
Average shareholder expectationRevenue Estimate
$87.62 B
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$0.30
Average shareholder expectationRevenue Estimate
$88.55 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Pharmaceuticals Holding Co., Ltd
49,608 employees
CEO: Qiuhua Yang Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company based in Shanghai, People's Republic of China, maintains a robust presence across the pharmaceutical and healthcare industries. Its core activities involve the res...